|Articles|November 7, 2011
Hepatitis C Birth Cohort Screening is Cost-Effective
Advertisement
Birth cohort screening can be a cost-effective strategy to identify individuals infected with hepatitis C virus (HCV), according to a study published online Nov. 4 in the Annals of Internal Medicine.
Investigators from the National Opinion Research Center at the University of Chicago in Atlanta found that, compared to the current system, an additional 808,580 cases of chronic HCV were detected through birth cohort screening.
“Birth cohort screening for HCV in primary care settings was highly cost-effective,” the authors write.
Further details are available at:
Sources: HealthDay; MDNews.com
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
3
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
4
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
5